Last10K.com

Kitov Pharma Ltd. (KTOV) SEC Filing 6-K Foreign Issuer report for the period ending Monday, May 4, 2020

Kitov Pharma Ltd.

CIK: 1614744 Ticker: KTOV

View differences made from one to another to evaluate Kitov Pharma Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Kitov Pharma Ltd..

Continue

Assess how Kitov Pharma Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Kitov Pharma Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Kitov Pharma Ltd. provided additional information to their SEC Filing as exhibits

Ticker: KTOV
CIK: 1614744
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001213900-20-010857
Submitted to the SEC: Mon May 04 2020 8:56:51 AM EST
Accepted by the SEC: Mon May 04 2020
Period: Monday, May 4, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ktov/0001213900-20-010857.htm